Company profile

EXOZYMES INC. CIK 2010788

Ticker

EXOZ (Nasdaq)

Industry

Biological Products, (No Diagnostic Substances)

Headquarters

Monrovia, CA 91016

Fiscal year end

2025 (FY)

Market Data

$5.73

Change

+$0.00

Change %

0.00%

Volume

EXOZ · trading date Oct 9, 2026 · previous close $5.73 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials

Revenue

—

Net income

-$9.16M

Total assets

$5.97M

Total liabilities

$2.57M

Stockholders' equity

$3.40M

Cash & equivalents

$3.04M

Operating income

-$9.72M

Operating cash flow

-$6.50M

Capital expenditures

$169.9K

Fiscal year 2025, via 10-K filed 2026-03-30. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance

Operating margin

—

Net margin

—

Free cash flow

-$6.67M

Free cash flow margin

—

Liabilities / assets

43.1%

Equity / assets

56.9%

CapEx / revenue

—

Operating cash flow / net income

0.71×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History

Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity

2025 — -$9.16M $5.97M $2.57M $3.40M

2024 — -$5.86M $13.03M $2.61M $10.42M

2023 $70.1K -$2.04M $3.56M $3.94M -$384.3K

Company Details

SIC code

2836

State of incorporation

Active filer

Yes

Most recent SEC filing

Form 8-K

2026-09-18

Financials filed via

Form 10-K

filed 2026-03-30

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location

Monrovia, CA 91016

750 ROYAL OAKS DR

Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:20 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies